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Introduction. Epidural analgesia has been a cornerstone of any ERAS program for open colorectal surgery. With the improvements
in anesthetic and analgesic techniques as well as the introduction of the laparoscopy for colorectal resection, the role of epidural
analgesia has been questioned. The aim of the review was to assess through a meta-analysis the impact of epidural analgesia
compared to other analgesic techniques for colorectal laparoscopic surgery within an ERAS program.Methods. Literature research
was performed on PubMed, Embase, and the Cochrane Library. All randomised clinical trials that reported data on hospital stay,
postoperative complications, and readmissions rates within an ERAS program with and without an epidural analgesia after a
colorectal laparoscopic resection were included. Results. Five randomised clinical trials were selected and a total of 168 patients
submitted to epidural analgesia were compared to 163 patients treated by an alternative analgesic technique. Pooled data show a
longer hospital stay in the epidural group with a mean difference of 1.07 (95% CI 0.06–2.08) without any significant differences in
postoperative complications and readmissions rates. Conclusion. Epidural analgesia does not seem to offer any additional clinical
benefits to patients undergoing laparoscopic colorectal surgery within an ERAS program.
1. Introduction
Since the early reporting of fast-track surgery, epidural
analgesia has been considered a cornerstone of such a
recovery program [1]. It is widely perceived that epidural
analgesia alters the stress response after surgery, improves
pain control, and consequently reduces cardiovascular and
infectious complications [2]. However, a recentmeta-analysis
on the role of epidural analgesia within an enhanced recovery
after surgery (ERAS) program in open surgery has reported
better pain control but no reduction in postoperative stay and
in complications rates with epidural analgesia compared to
other analgesic techniques [3].
In colorectal surgery, the laparoscopic technique has been
widely adopted as a safe alternative to open surgery due to
its beneficial effects on the reduction of postoperative pain
and postoperative ileus, which can shorten the length of
hospital stay [4]. Laparoscopy is supposed to induce a weaker
neuroendocrine response to the surgical trauma to a level that
could permit one to not include the epidural analgesia within
the ERAS program.The finding that epidural analgesia, both
within and outside any ERAS program, does not affect the
length of hospital stay after laparoscopic colorectal surgery
may support this hypothesis [5]. Moreover a recent review
has reported that an ERAS programmay reduce hospital stay
after laparoscopic colorectal surgery while the laparoscopic
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approach may reduce morbidity when compared to the open
approach within an ERAS program [6].
These results question the role of epidural analgesia in
laparoscopic colorectal surgery within an ERAS program.
However, reporting of results on epidural analgesia is hetero-
geneous across different studies and no single study provides
a level of evidence high enough to draw definitive conclusions
on the exact role of epidural analgesia in laparoscopic
colorectal surgery within an ERAS program [7–13].
This study aims to systematically review the literature
reporting on the impact of epidural analgesia with laparo-
scopic colorectal surgery when delivered within an ERAS
program and to conduct a meta-analysis of the results of
randomised controlled studies.
2. Methods
The meta-analysis was performed according to the PRISMA
statement for reporting reviews and meta-analysis [14].
The present review was not registered on the PROSPERO
database for meta-analysis.
2.1. Literature Research. Literature research was conducted
on PubMed, Embase, and the Cochrane Library with the fol-
lowing term strategy: (((((((epidural) OR eras) OR enhanced
recovery) OR fast track) OR rehabilitation)) AND ((((colon
surgery) OR colorectal surgery)) AND laparoscop∗)) AND
((randomized) OR randomised); and it was completed by
hand search of the selected studies.
2.2. Eligibility Criteria. Studies published between January
2000 and January 2016 were included to promote the cap-
ture of all papers published since ERAS was most widely
implemented in clinical practice. The title and the abstract
were checked for a first selection of relevant studies; papers
were selected for full reading and a second selection was
performed through the review of the entire article. Papers
were selected for inclusion in the meta-analysis only if they
reported a randomised controlled trial comparing epidural
analgesia with other analgesic techniques within an ERAS
program in laparoscopic colorectal surgery, and they reported
the data related to at least one of the following: hospital
stay, postoperative complications rate, and readmissions rate.
Papers that compared epidural and spinal analgesia were
not included. No language restriction was applied. Case
studies, nonrandomised comparative studies, and studies
which did not report an ERAS program were excluded.
Abstracts and conference proceedings were excluded because
of the probability of incomplete data.
2.3. Data Extraction and Methodological Quality. Data were
extracted and crosschecked from the papers by two indepen-
dent authors. Since patients are not usually discharged until
full recovery, the postoperative hospital staywas chosen as the
main efficacy outcome for the meta-analysis. For assessment
of the effect of the analgesic method of the recovery program
on safety, postoperative complications and readmission rates
were also extracted for the pooled analysis. A sensitivity
analysis was performed by analysing the estimated results
with both the random and the fixed effect model, by dividing
the studies according to the alternative analgesic technique,
by eliminating discordant studies according to the design of
the studies.The following data were collected for a secondary
analysis: pain scores, functional outcomes such as time to
first flatus, time to first bowel movement, time to resolution
of postoperative nausea and vomiting (PONV), or rate of
patients with PONV and time to oral diet intake. All the
authors have been contacted and have been asked to provide
lacking data and to provide data as mean values and their SD
for continuous variables, when necessary. Two independent
reviewers reviewed the studies. Methodological quality of
the randomised studies was assessed using the Cochrane
collaborations tool for assessing risk of bias [15].
2.4. Statistical Analysis. When continuous variables were
given as a median and range or interquartile range (IQR),
transformation in mean and standard deviation was per-
formed by the described methods of Hozo et al. [16] and
Wan et al. [17]. The weighted mean difference (WMD) and
the 95% confidence interval were calculated for the pooled
estimation of continuous variables, and the relative risk (RR)
and the 95% confidence interval were calculated for the
pooled estimation of dichotomous variables.
Since selected studies report a comparison between
epidural analgesia and other different analgesic techniques,
heterogeneity of results was expected; the random effect
model was therefore adopted and data pooled using the
DerSimonian Laird method [18]. Heterogeneity was esti-
mated with the 𝜒2 test and the 𝐼2 statistic. Heterogeneity
was excluded when 𝐼2 was less than 30% [19, 20]. The meta-
analysis was conducted using the ReviewManager (RevMan)
computer program Version 5.3 [21].
3. Results
A PRISMA diagram of selected studies is summarised in
Figure 1. The search strategy identified 125 abstracts, from
which 3 duplicates were removed, leaving 122 papers. A
further 115were excluded by review of the title and/or abstract
because they did not meet the eligibility criteria, leaving
a total of 7 papers selected for a full paper reading. One
study was eliminated because the ERAS programme was not
described or evenmentioned in the text, and another one was
eliminated because it reported a post hoc analysis of another
trial, leaving 5 randomised clinical trials included in this
study for data extraction and meta-analysis. This included a
total of 168 patients treated by epidural analgesia and 163 by
another analgesic technique.
The characteristics and details of the included studies
are summarised in Table 1. The bias assessment is reported
in Figure 2. All studies were randomised but among them
only one reported blinding; it was however a pilot study and
no hypothesis or no sample size calculation was provided
[10]. Intention to treat analysis was not performed in all
studies [7–9, 11] because of the noninclusion of some patients
after randomisation. The alternative analgesic techniques to
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Figure 1: PRISMA diagram of study selection.
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Figure 2: Risk of bias assessment.
which epidural analgesia was compared were heterogeneous
among studies. In one study epidural analgesia was evaluated
as an add-on to an IV analgesic regimen [7], one study
compared epidural analgesia with spinal analgesia and IV
PCA [8], another one study compared epidural analgesia to
intravenous patient controlled analgesia (IV PCA) [11] within
a slightly different protocol, one study compared epidural
analgesia with IV lidocaine [9] and another onewith a wound
infusion catheter [10]. The items of the ERAS program were
clearly listed in three studies [7–9] while in two studies the
items were not listed; the ERAS program the study referred
to was just mentioned or cited [10, 11].
3.1. Quantitative Analysis. The length of hospital stay was
reported in all five studies and was statistically longer in
the epidural groups than in alternative analgesic technique
groups with a WMD of 1.07 (95% CI 0.06–2.08) as shown in
Figure 3. However a significant heterogeneity was found with
𝐼
2 being 58%.
Postoperative complications were reported in all the five
studies; no difference was found between the epidural regi-
men and other analgesic techniques with RR of 1.1 (95% CI
0.75–1.63) as shown in Figure 4. No significant heterogeneity
was found.
Rates of readmission were reported in four studies; no
difference was found between the epidural regimen and other
analgesic techniques with RR of 1.01 (95% CI 0.46–2.19) as
shown in Figure 5. No heterogeneity was found.
3.2. Sensitivity Analysis. No different results were found by
estimating pooled data with the fixed effect model. The
estimated WMD of hospital stay was 0.98 (95% CI 0.4–1.56),
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Study or subgroup
Total (95% CI)
Mean SD Total
Weight
Epidural analgesia
Mean SD Total
Control Mean difference
IV, random, 95% CI
Mean difference
Favours [TEA] Favours [control]
IV, random, 95% CI
5.33
3.93
4.6
7.83
3.75
1.82
2.84
5.56
29
30
14
65
168
4.28
3.7
7.05
5.7
2.02
1.6
8.86
2.96
29
30
17
57
163
20.1%
29.8%
4.5%
20.1%
100.0%
1.05 [−0.50, 2.60]
2.13 [0.58, 3.68]
1.07 [0.06, 2.08]
−2.45 [−6.92, 2.02]
0.23 [−0.64, 1.10]
4.56 3.11 30 2.7 0.86 30 25.5% 1.86 [0.71, 3.01]
Test for overall effect: Z = 2.08 (p = 0.04)
−10 −5 0 5 10Heterogeneity: 𝜏
2 = 0.69; 𝜒2 = 9.48, df = 4 (p = 0.05); I2 = 58%
Boulind et al. 2013
Levy et al. 2011
Turunen et al. 2009
Wongyingsinn et al. 2011
Hübner et al. 2015
Figure 3: Hospital stay.
Study or subgroup
Total (95% CI)
Total events
Weight
Total
Control Risk ratio
M-H, random, 95% CI
Risk ratio
M-H, random, 95% CI
Favours [TEA] Favours [control]
5
8
56
Events
11
8
48
29
30
168
29
30
163
15.0%
17.6%
100.0%
0.45 [0.18, 1.14]
1.10 [0.75, 1.63]
1.00 [0.43, 2.31]
3 314 17 6.8% 1.21 [0.29, 5.10]
30 1965 57 42.4% 1.38 [0.88, 2.17]
10 730 30 18.2% 1.43 [0.63, 3.25]
Test for overall effect: Z = 0.50 (p = 0.62)
0.01 0.1 1 10 100
Events Total
Epidural analgesia
Heterogeneity: 𝜏2 = 0.04; 𝜒2 = 4.95, df = 4 (p = 0.29); I2 = 19%
Boulind et al. 2013
Levy et al. 2011
Turunen et al. 2009
Wongyingsinn et al. 2011
Hübner et al. 2015
Figure 4: Postoperative complications.
Study or subgroup
Total (95% CI)
Total events
Events Total
Weight
Epidural analgesia
Total
Control Risk ratio
M-H, random, 95% CI
Risk ratio
M-H, random, 95% CI
Favours [TEA] Favours [control]
1
7
1
3
12
Events
3
7
1
0
11
29
30
14
65
138
29
30
17
57
133
12.5%
72.1%
8.4%
7.0%
100.0%
0.33 [0.04, 3.02]
6.15 [0.32, 116.61]
1.01 [0.46, 2.19]
1.21 [0.08, 17.71]
1.00 [0.40, 2.50]
Test for overall effect: Z = 0.02 (p = 0.99)
0.01 0.1 1 10 100Heterogeneity: 𝜏2 = 0.00; 𝜒2 = 2.47, df = 3 (p = 0.48); I2 = 0%
Boulind et al. 2013
Turunen et al. 2009
Wongyingsinn et al. 2011
Hübner et al. 2015
Figure 5: Readmissions.
the estimated RR of postoperative complications rate was 1.11
(95%CI 0.81–1.53), and the estimated RR of readmissions was
1.08 (95% CI 0.51–2.27).
By restricting the data estimations to studies using the
same alternative analgesic technique [8, 11], a higher dif-
ference of postoperative stay was found between epidural
analgesia and IV PCA. By pooling data from the studies by
Levy et al. [8] and Hu¨bner et al. [11], the estimated WMD
of postoperative stay was 1.96 (95% CI 1.03–2.88) favouring
IV PCA. No significantly different results were found with
estimated RR of postoperative complications, which was 1.39
(95% CI 0.94–2.07). The estimated RR of readmission could
not be calculated since Levy et al. did not specify the rate of
readmissions.
By eliminating the study by Wongyingsinn et al., which
included low rectal surgery with ileostomy, and that by
Boulind et al., which was a pilot study on blinding feasibility,
a higher difference in postoperative stay was found. The
estimated WMD was 1.72 (95% CI 0.92–2.51), while no
difference was found in postoperative complications with an
estimated RR of 1.04 (95% CI 0.55–1.99) and in readmission
with an estimated RR of 1.21 (95% CI 0.07–21.65).
3.3. Secondary Outcomes Analysis. A qualitative analysis was
performed for the secondary outcomes because of limited
homogeneity in the reporting of data.
The patients’ pain score was assessed by a visual analogue
scale or by verbal rate scale in all studies but reporting and
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results were heterogeneous among the studies. The study by
Boulind et al. reported better pain control with epidural at
D0 but not at D2; mean pain scores with SD were 0.6 (0.4)
with epidural and 3.4 (2) with wound infusion catheter on
D0, 2.4 (2) with epidural, and 2.6 (2.2) with wound infusion
catheter on D1, while pain scores were 3.2 (3.1) with epidural
and 2.4 (2.9) with wound infusion catheter on D2 but no
statistical evaluation was reported [10]. The study by Levy et
al. [8] found that pain score was significantly better in the
epidural group atD0 both at rest and onmovement, reporting
a median value with IQR of VAS on movement of 4,5 (IQR
2,8–6) with epidural and 7 (IQR 6–8) with PCA (𝑝 < 0.001);
but no significant differences on pain scores were found at D1
and D2 between epidural and PCA. In the study by Turunen
et al. [7] rates of patients with significant pain (VAS ≥ 3) were
compared, finding no difference at rest (𝑝 = 0.171) but a
higher number of patients with pain at mobilisation in the
nonepidural group (𝑝 = 0.001). The study by Wongyingsinn
et al. [9] reported a median value and IQR for colon and
rectal surgery separately. No differences were reported in
the pain scores at rest, on coughing, and on walking after
colonic surgery, while a better pain control was registered
with epidural analgesia after rectal surgery at rest with pain
scores of 0 (0–2) versus 3 (1.5–3) (𝑝 = 0.023) at D1 and 0
(0–2) versus 3 (1–3) (𝑝 = 0.008) at D2. The study by Hu¨bner
et al. [11] found no significant differences between epidural
analgesia and PCA; the authors reported detailed data on a
figure.
Three studies reported data on the time to first flatus.
No differences were found between epidural analgesia and
alternative analgesic techniques in all the studies. Turunen
et al. [7] reported a median value of 1 (1–4) day both in the
epidural group and in the control group (𝑝 = 0.219). Levy et
al. [8] reported median values of 1.5 (IQR 0.9–2.2) days in the
epidural group and 1.6 (IQR 1.2–2) days in the PCA group (p
not reported). Wongyingsinn et al. [9] reported in the colon
surgery group without ileostomy a mean value of 24 hours
(95% CI 19–29) in the epidural group and 27 hours (95% CI
22–32) in the IV lidocaine group (𝑝 = 0.38).
Three studies reported data on the time to first bowel
movement. No differences were found between epidural
analgesia and alternative analgesic techniques in all the
studies. Turunen et al. [7] reported a median value of 2 (1–
9) days in the epidural group and 2 (1–7) days in the control
group (𝑝 = 0.56). Levy et al. [8] reported median values of
3.1 (IQR 2.25–4.75) days in the epidural group and 4 (IQR
2.43–4.55) days in the PCAgroup (𝑝 = 0.346).Wongyingsinn
et al. [9] reported in the primary anastomosis group without
ileostomy a mean value of 44 hours (95% CI 35–52) in the
epidural group and 43 hours (95% CI 34–52) in the IV
lidocaine group (𝑝 = 0.887).
Two studies reported data on PONV with discordant
results. Levy et al. [8] reported a longer duration of nausea
and vomiting in the epidural group with median values,
respectively, of 1.7 (IQR 0.95–4.45) versus 0.55 (IQR 0–1.55)
days (𝑝 = 0.006) for nausea and 1 (IQR 0–2.15) versus 0 (IQR
0–0.25) days (𝑝 = 0.008) for vomiting. Wongyingsinn et al.
[9] reported no different rates of patients having suffered of
nausea with rates of 57% in the epidural groups versus 37% in
the IV lidocaine group (𝑝 = 0.438) and of vomiting with rates
of 60% in the epidural group versus 40% in the IV lidocaine
group (𝑝 = 0.791).
Similar results were reported for time to oral intake. In the
study by Levy et al. [8], the time to oral intake was longer in
the epidural group with a median of 2 (IQR 1.29–4.6) versus
1.43 (IQR 0.8–2.3) days (𝑝 = 0.02). No difference was found
in the study by Wongyingsinn et al. [9] with a mean time of
oral intake of 35 hours (95% CI 22–51) in the epidural group
versus 38 hours (95% CI 22–46) in the IV lidocaine group
(𝑝 = 0.894).
4. Discussion
The present meta-analysis summarised the reporting of five
randomised controlled trials evaluating the impact of epidu-
ral analgesia following laparoscopic colorectal surgery within
an ERAS program.This review found that there was a signifi-
cantly longer hospital stay, without any significant difference
in postoperative complications and readmissions rates in
the group of patients managed with an epidural analgesia
compared to other analgesic techniques.Themean difference
in hospital stay may be considered as fairly relevant, since
patients with epidural analgesia were discharged 1 day later
than patients treated with other analgesic techniques.
All included studies in the present meta-analysis are
randomised and in all studies [7–12] the random sequence
generation and allocation concealment were reported and
were unclear just in one study, giving strength to the results
of the meta-analysis. However, although blinding is very
important when evaluating pain control, only the study by
Boulind et al. [10] was blind. It was furthermore a pilot
study on the feasibility of blinding in randomised studies on
epidural analgesia; it was not designed to explore a clinical
hypothesis and no sample size calculation was performed.
Finally the designs of the included studies were not homo-
geneous; different analgesic alternative techniques had been
investigated; the explored hypothesis and the main measured
outcome were different for each of the included studies.
A significant heterogeneity test and a 58% inconsistency
index were found with pooled data on hospital stay. By
eliminating one pilot study and one study that included low
rectal surgery with ileostomy, a more significant difference
was found, up to 1.72 days with no heterogeneity, givingmore
strength to the result of a longer hospital stay with epidural
analgesia compared to other analgesic techniques.The length
of postoperative hospital stay reflects the quality of the
postoperative course since a confident degree of autonomy
needs to be raised before discharge. Discharge may however
be influenced by the subjectivity of any medical decisions, by
socioeconomic factors and expectance of patients, which are
independent of the investigation but all are supposed not to
influence comparisons in a randomised setting. In the present
meta-analysis, on one hand the length of hospital stay was
significantly shorter in the alternative analgesic technique
group, but no differences have been found in most of the
single criteria generally used to discharge. Although some of
them have been reviewed only through a qualitative analysis,
no differences were found in postoperative complications
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rate, time to flatus, and time to first bowel movement. The
study by Levy et al. [8] reported a longer period of PONV and
time to oral diet intake in the epidural group. Considering
the number of included patients in the study by Levy et al.,
the shorter duration of PONV compared to time to discharge,
there is low probability that the study has influenced results
of the meta-analysis on postoperative length of stay. Based
on these considerations and on the absence of homogeneous
criteria for patient discharge in the selected papers, a possible
bias on the length of hospital stay cannot be excluded.
When considering the pooled data on safety, the power
of the meta-analysis should be interpreted with some degree
of caution given the lack of difference on postoperative
complications and readmissions rates. Nevertheless, consid-
ering the number of patients included in the pooled analysis
and the absence of significant heterogeneity, the results may
be considered being at low risk of underestimation of any
difference between the effects of epidural and alternative
analgesic techniques on postoperative complications and
readmissions rates.
Literature data on the role of epidural analgesia in
colorectal surgery are still controversial. According to the
more recent guidelines, positioning of an epidural catheter
is strongly recommended in open colon surgery but could
be probably avoided in laparoscopic colorectal surgery with,
however, a low grade of recommendation [22, 23]. The
present review supports the latter recommendation based on
reviewing the randomised controlled trials in this area. This
is, to our knowledge, the first meta-analysis on the effect of
epidural analgesia within an ERAS program in laparoscopic
colorectal surgery.
Epidural analgesia has been advocated for postoperative
pain control, for the management of the neuroendocrine
response, and for its effects on postoperative stay [1, 2]. A
retrospective study [24] and two randomised studies [25,
26] both reported that epidural analgesia outside an ERAS
program improved pain control in laparoscopic colorectal
surgery. A randomised study on laparoscopic sigmoid resec-
tion did not report pain control improvement with epidural
analgesia, but only 20 patients were included [27].The results
of the present review on pain control are heterogeneous.
Furthermore, it must be underlined that both epidural and
other analgesic techniques were provided as an add-on to
IV antalgic treatment regimen in all the studies; risk of
confounding or attenuating the effect of the randomised
analgesic techniques cannot therefore be excluded. The
advantages of an ERAS program including epidural analgesia
in laparoscopic colorectal surgery have been reported, both
by comparison to open surgery within an ERAS program [28]
and by comparison of an ERAS program versus conventional
carewithin laparoscopic colorectal surgery [29, 30].Theques-
tion however remains on whether epidural analgesia offers
any additional benefits, through neuroendocrine blockage,
to laparoscopic surgery within an ERAS program. The role
of other items in an ERAS program other than epidural
analgesia should be investigated, since no high level of
evidence-based studies on this issue has been found [22, 23].
The effects of epidural analgesia on the length of hospital
stay outside an ERAS program have been reported in two
studies. A randomised study reported that epidural analgesia
did not affect the length of hospital stay in laparoscopic
colorectal surgery [25] and a retrospective study based on
a trial database found that laparoscopy was an independent
predictive factor of early recovery, but epidural analgesia was
not [31].
Side effects and feasibility of the epidural analgesia were
not reported in the present review; however they should
be taken into account when deciding to recommend or not
the epidural analgesia. The side effects of epidural analgesia
have not been reported to be significantly higher than with
other analgesic techniques [6], but epidural analgesia may
be the cause of rare but serious complications such as
epidural hematoma and neurological sequels [4]. Moreover,
the placement of a catheter for the epidural analgesia is not
always successful; rates of failure from 13% to 32% have been
reported in major abdominal surgery [32].
The meta-analysis has some limits. The review has
included studies where the sample size was not assessed for
the length of hospital stay, which is the main outcome of
the meta-analysis, except that of Levy et al. [8]. Only one
included study was blinded, and it was a pilot study with
no exploration of any clinical hypothesis [10]. Design of the
studies and the alternative analgesic techniques compared to
epidural analgesia were heterogeneous among the included
trials, and most important for the clinical implication the
items of the ERAS programs were not well described in all
the studies and were not homogenous.
The present meta-analysis confirmed that epidural anal-
gesia might not offer any additional clinical benefits to
patients undergoing laparoscopic colorectal surgery within
an ERAS program. However, the results of this review are
limited by the number of studies and should be interpreted
with some degree of caution. A further large multicentre
randomised controlled trial appears necessary to definitively
recommend not performing an epidural analgesia within an
ERAS program in colorectal surgery.
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